These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30095329)

  • 61. Transcriptome analyses demonstrate that Peroxisome Proliferator-Activated Receptor α (PPARα) activity of an ultraviolet absorber, 2-(2'-hydroxy-3',5'-di-tert-butylphenyl)benzotriazole, as possible mechanism of their toxicity and the gender differences.
    Hirata-Koizumi M; Ise R; Kato H; Matsuyama T; Nishimaki-Mogami T; Takahashi M; Ono A; Ema M; Hirose A
    J Toxicol Sci; 2016; 41(5):693-700. PubMed ID: 27665778
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion.
    Jiang R; Tang J; Chen Y; Deng L; Ji J; Xie Y; Wang K; Jia W; Chu WM; Sun B
    Nat Commun; 2017 May; 8():15129. PubMed ID: 28541302
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of C-5 propynyl pyrimidine-containing oligonucleotides in vitro and in vivo.
    Shen L; Siwkowski A; Wancewicz EV; Lesnik E; Butler M; Witchell D; Vasquez G; Ross B; Acevedo O; Inamati G; Sasmor H; Manoharan M; Monia BP
    Antisense Nucleic Acid Drug Dev; 2003; 13(3):129-42. PubMed ID: 12954113
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mouse genome-wide association studies and systems genetics uncover the genetic architecture associated with hepatic pharmacokinetic and pharmacodynamic properties of a constrained ethyl antisense oligonucleotide targeting Malat1.
    Pirie E; Ray S; Pan C; Fu W; Powers AF; Polikoff D; Miller CM; Kudrna KM; Harris EN; Lusis AJ; Crooke RM; Lee RG
    PLoS Genet; 2018 Oct; 14(10):e1007732. PubMed ID: 30372444
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long noncoding RNAs in hepatitis B virus-related hepatocellular carcinoma.
    Yu TT; Xu XM; Hu Y; Deng JJ; Ge W; Han NN; Zhang MX
    World J Gastroenterol; 2015 Jun; 21(23):7208-17. PubMed ID: 26109807
    [TBL] [Abstract][Full Text] [Related]  

  • 66. LNA-antisense rivals siRNA for gene silencing.
    Jepsen JS; Wengel J
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):188-94. PubMed ID: 15603252
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In vitro and in vivo properties of therapeutic oligonucleotides containing non-chiral 3' and 5' thiophosphate linkages.
    Duschmalé J; Hansen HF; Duschmalé M; Koller E; Albaek N; Møller MR; Jensen K; Koch T; Wengel J; Bleicher K
    Nucleic Acids Res; 2020 Jan; 48(1):63-74. PubMed ID: 31754711
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Development and Clinical Applications of Antisense Oligonucleotide Gapmers.
    Chan L; Yokota T
    Methods Mol Biol; 2020; 2176():21-47. PubMed ID: 32865780
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antisense oligonucleotide gapmers containing phosphoryl guanidine groups reverse MDR1-mediated multiple drug resistance of tumor cells.
    Kupryushkin MS; Filatov AV; Mironova NL; Patutina OA; Chernikov IV; Chernolovskaya EL; Zenkova MA; Pyshnyi DV; Stetsenko DA; Altman S; Vlassov VV
    Mol Ther Nucleic Acids; 2022 Mar; 27():211-226. PubMed ID: 34976439
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Transcriptome profiling analysis of differentially expressed mRNAs and lncRNAs in HepG2 cells treated with peptide 9R-P201.
    Liu W; Ding R; Zhang Y; Mao C; Kang R; Meng J; Huang Q; Xiong L; Guo Z
    Biotechnol Lett; 2017 Nov; 39(11):1639-1647. PubMed ID: 28762034
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3.
    Zhu XT; Yuan JH; Zhu TT; Li YY; Cheng XY
    FEBS J; 2016 Oct; 283(20):3739-3754. PubMed ID: 27573079
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Long Noncoding RNA Transcriptome of
    Rosengarten RD; Santhanam B; Kokosar J; Shaulsky G
    G3 (Bethesda); 2017 Feb; 7(2):387-398. PubMed ID: 27932387
    [No Abstract]   [Full Text] [Related]  

  • 74. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.
    Meng F; Henson R; Wehbe-Janek H; Ghoshal K; Jacob ST; Patel T
    Gastroenterology; 2007 Aug; 133(2):647-58. PubMed ID: 17681183
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Analysis of hypoxia-induced noncoding RNAs reveals metastasis-associated lung adenocarcinoma transcript 1 as an important regulator of vascular smooth muscle cell proliferation.
    Brock M; Schuoler C; Leuenberger C; Bühlmann C; Haider TJ; Vogel J; Ulrich S; Gassmann M; Kohler M; Huber LC
    Exp Biol Med (Maywood); 2017 Mar; 242(5):487-496. PubMed ID: 28056547
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibition of MALAT1 sensitizes liver cancer cells to 5-flurouracil by regulating apoptosis through IKKα/NF-κB pathway.
    Ji DG; Guan LY; Luo X; Ma F; Yang B; Liu HY
    Biochem Biophys Res Commun; 2018 Jun; 501(1):33-40. PubMed ID: 29702091
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comprehensive Analysis of Long Noncoding RNAs and Messenger RNAs Expression Profiles in Patients with Marjolin Ulcer.
    Liu Z; Ren L; Tian J; Liu N; Hu Y; Zhang P
    Med Sci Monit; 2018 Nov; 24():7828-7840. PubMed ID: 30385735
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1.
    Ding CH; Yin C; Chen SJ; Wen LZ; Ding K; Lei SJ; Liu JP; Wang J; Chen KX; Jiang HL; Zhang X; Luo C; Xie WF
    Mol Cancer; 2018 Feb; 17(1):63. PubMed ID: 29466992
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Specificity of RNAi, LNA and CRISPRi as loss-of-function methods in transcriptional analysis.
    Stojic L; Lun ATL; Mangei J; Mascalchi P; Quarantotti V; Barr AR; Bakal C; Marioni JC; Gergely F; Odom DT
    Nucleic Acids Res; 2018 Jul; 46(12):5950-5966. PubMed ID: 29860520
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Liver as a target for oligonucleotide therapeutics.
    Sehgal A; Vaishnaw A; Fitzgerald K
    J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.